Description

Trading approval for 24,42,000 equity shares of Shelter Pharma Limited issued on preferential basis at Rs. 42.25 per share with lock-in periods until June 2026 and June 2027.

Summary

Shelter Pharma Limited has applied for trading of 24,42,000 equity shares of face value Rs. 10/- per share issued on preferential basis at Rs. 42.25 per share (including premium of Rs. 32.25 per share). The shares were allotted in two tranches on October 1, 2025 and October 3, 2025, with lock-in periods extending until June 2026 and June 2027.

Key Points

  • Total shares issued: 24,42,000 equity shares
  • Face value: Rs. 10/- per share
  • Issue price: Rs. 42.25 per share (premium of Rs. 32.25)
  • Allotment dates: October 1, 2025 and October 3, 2025
  • Distinctive numbers range: 1,15,59,793 to 1,40,01,792
  • Lock-in dates: June 29-30, 2026 and June 30, 2027
  • Managing Director: Mustaqim Nisarahmed Sabugar (DIN: 01456841)

Regulatory Changes

No regulatory changes announced.

Compliance Requirements

  • Allottees must comply with lock-in period requirements
  • Shares allotted on October 1, 2025: Lock-in until June 29-30, 2026
  • Shares allotted on October 3, 2025: Lock-in until June 30, 2026 and June 30, 2027

Important Dates

  • Allotment Date 1: October 1, 2025
  • Allotment Date 2: October 3, 2025
  • Lock-in Expiry (Tranche 1): June 29-30, 2026
  • Lock-in Expiry (Tranche 2): June 30, 2026 and June 30, 2027

Impact Assessment

Minimal immediate market impact as all preferentially allotted shares are subject to lock-in periods. The shares cannot be traded until their respective lock-in dates expire. This is a standard listing process for preferential allotment with appropriate investor protections through staggered lock-in requirements.

Impact Justification

Routine listing of preferential allotment shares with standard lock-in requirements. Limited market impact as shares are locked in.